CYTOKINETICS INC — Director's Dealing 2025

Sep 10, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2025-09-09

Reporting Person: Malik Fady Ibraham (EVP Research & Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-09-09	Common Stock	M	2000	$10.60	Acquired	142610	Direct
2025-09-09	Common Stock	S	2000	$51.29	Disposed	140610	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-09-09	Non-Qualified Stock Option (Right to Buy)	$10.60	M	2000	Disposed	2027-02-28	Common Stock (2000)	Direct